绝经后女性血浆雌二醇国际协调参考范围的建立
该研究基于5个国际队列共7206名未使用外源性雌激素的绝经后女性,主要采用液相色谱-串联质谱法测定雌二醇,并通过重测子样本与CDC参考测量程序校准实现协调。结果显示雌二醇浓度与BMI相关而与年龄无关,全体参考范围为1.1-18.2 pg/mL,非肥胖女性为1.1-12.5 pg/mL,且参考范围随BMI类别升高而递增。
要点
- 绝经后女性雌二醇参考范围需按BMI分层解读
- 全体参考范围2.5-97.5百分位为1.1-18.2 pg/mL
- 非肥胖女性参考范围为1.1-12.5 pg/mL
核心结论
- 通过CDC参考测量程序交叉校准,建立了未使用外源性雌激素的绝经后女性协调血浆雌二醇参考范围。
- 绝经后女性肥胖程度增加与雌二醇浓度升高相关,支持按BMI类别制定参考范围。
研究设计与样本
- 研究纳入5个国际队列的社区居住绝经后女性,主要来自欧洲裔,年龄38-100岁,未使用外源性雌激素,共7206名。
- 雌二醇主要采用液相色谱-串联质谱法测定,并通过重测各队列子样本生成重校准方程,与CDC参考测量程序协调。
主要发现
- 不同LC-MS/MS测定的雌二醇浓度与CDC参考测量程序高度相关,协调化最小化了测定间变异。
- 雌二醇浓度与BMI相关,但与实际年龄无关。
- 全体绝经后女性参考范围(2.5-97.5百分位)为1.1-18.2 pg/mL(4.0-66.8 pmol/L),中位数4.9 pg/mL(18.0 pmol/L)。
- 非肥胖女性(BMI<30)参考范围为1.1-12.5 pg/mL(4.0-45.9 pmol/L),中位数4.1 pg/mL(15.1 pmol/L)。
- 参考范围随BMI类别升高而逐渐增加。
关键数值与推荐
- 全体绝经后女性雌二醇参考范围:1.1-18.2 pg/mL(4.0-66.8 pmol/L),中位数4.9 pg/mL(18.0 pmol/L)。
- 非肥胖(BMI<30)绝经后女性参考范围:1.1-12.5 pg/mL(4.0-45.9 pmol/L),中位数4.1 pg/mL(15.1 pmol/L)。
临床怎么用
- 解读绝经后女性血浆雌二醇浓度时应考虑BMI分层,避免统一参考范围造成误判。
- 该协调参考范围适用于未使用外源性雌激素的绝经后女性,可用于评估全身或局部雌二醇治疗时的浓度。
局限性
- 研究人群主要为欧洲裔社区居住绝经后女性,外推至其他种族需谨慎。
- 原文未报告参考范围在特定疾病风险预测中的临床效用,需未来研究建立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Prior reports of plasma estradiol concentrations and their reference ranges in postmenopausal women identified marked variation, in part due to assay method and body mass index (BMI). OBJECTIVE: To develop an international reference range for plasma estradiol in postmenopausal women, support accurate assessment of concentrations during systemic and local (eg, vaginal) estradiol therapy, and improve risk prediction for diseases, including osteoporosis, breast, and endometrial cancers. METHODOLOGY: Estradiol concentrations were measured using primarily liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays in 5 international cohorts of community-dwelling, postmenopausal women of primarily European ancestry aged 38-100 years who were not using exogenous estrogens (n = 7206). Measurements were harmonized to the Centers for Disease Control and Prevention (CDC) reference measurement procedure (RMP) by re-assaying a subset of samples for each cohort and generating recalibration equations. Reference intervals were determined for all women, non-obese women, and specific BMI categories. RESULTS: Estradiol concentrations from separate LC-MS/MS assays correlated closely with the CDC RMP, and harmonization minimized inter-assay variability. Estradiol concentrations correlated with BMI but not with chronological age. The reference range (2.5th-97.5th percentile) was 1.1-18.2 pg/mL (4.0-66.8 pmol/L) with median of 4.9 pg/mL (18.0 pmol/L) for all postmenopausal women and 1.1-12.5 pg/mL (4.0-45.9 pmol/L) with median of 4.1 pg/mL (15.1 pmol/L) for non-obese women (BMI < 30). Reference ranges increased progressively with higher BMI categories. CONCLUSION: Cross-calibration of estradiol measurements with the CDC RP enabled the development of harmonized plasma estradiol reference ranges for postmenopausal women who were not using exogenous estrogens, suitable for future studies to establish clinical utility. Increasing obesity in postmenopausal women was associated with increasing estradiol concentration and BMI category-specific reference ranges.
引用
- Cui J, Hankinson SE, Matsumoto AM, et al. Establishment of harmonized international reference ranges for plasma estradiol concentrations in postmenopausal women. J Clin Endocrinol Metab. 2026. PMID: 42120349. doi:10.1210/clinem/dgag188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。